Skip to main content
FDA approves first twice-yearly antipsychotic for schizophrenia
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves first twice-yearly antipsychotic for schizophrenia
User login
Username
Password
Reset your password
Concept
Lead
score
Schizophrenia
1
1
Antipsychotics
0
0.99
Atypical Antipsychotics
0
0.98
Clinical Research
0
0.46
Food and Drug Administration (FDA)
0
0.97
Adherence
0
0.31
Deliberate Self-Harm
0
0.22
Upper Respiratory Tract Infection
0
0.22
Otolaryngology
0
0.17
California
0
0.15
Caregiver
0
0.15
Chronic Disease
0
0.15
Clinical Guidelines
0
0.15
Injury
0
0.15
Parkinsonian
0
0.15
Psychiatric Hospital
0
0.5
Respiratory Tract
0
0.15
Weight Gain
0
0.15
Headache
0
0.08
Parkinson Disease
0
0.08
Weight Management
0
0.08
Wound Management
0
0.08
Specialty
Lead
score
Psychiatry
1
1